Virus Filtration Market Share, Size, Trends, Segments And Forecast By 2023-28

(MENAFN- IMARC Group) The latest report by IMARC Group, titled“ Virus Filtration Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 “, The global virus filtration market size reached US$ 3.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2028, exhibiting a growth rate (CAGR) of 9.5% during 2023-2028.

Virus filtration plays a pivotal role in the pharmaceutical and biotechnology sectors, safeguarding products such as vaccines, antibodies, and therapeutic proteins against viral contaminants. This crucial process employs specialized membrane filters engineered to selectively capture viruses according to their size and specific attributes. By allowing smaller components like proteins to permeate while ensnaring larger viral particles, these filters ensure the safety and efficacy of medical treatments. Widely adopted across the globe, virus filtration stands as an indispensable element in the comprehensive strategy for virus clearance during the manufacture of biological products. Its efficacy underscores its significance as a standard quality assurance practice in biologics production.

Virus Filtration Market Trends and Drivers:

The global virus filtration market thrives on the growing demand for biopharmaceuticals like vaccines, monoclonal antibodies, and recombinant proteins, necessitating stringent virus filtration for safety and efficacy. Regulatory bodies such as the FDA and EMA impose strict virus clearance protocols, fueling the demand for advanced filtration technologies. Moreover, increasing chronic diseases drive the need for biological therapies, spurring the demand for dependable virus filtration solutions. Technological innovations in filtration materials and techniques further bolster market expansion by providing enhanced efficiency and scalability.

For an in-depth analysis, you can refer sample copy of the report:

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

  • Consumables
    • Kits and Reagents
    • Others
  • Instruments
    • Filtration Systems
    • Chromatography Systems
  • Services

Breakup by Application:

  • Biologicals
    • Vaccines and Therapeutics
    • Blood and Blood Products
    • Cellular and Gene Therapy Products
    • Others
  • Medical Devices
  • Water Purification
  • Air Purification
  • Others

Breakup by End Use:

  • Biopharmaceuticals and Biotechnology Companies
  • Contract Research Organizations
  • Academic Institutes and Research Laboratories
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Asahi Kasei Medical Co. Ltd.
  • Charles River Laboratories Inc.
  • Clean Cells
  • Danaher Corporation
  • Merck KGaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:


134 N 4th St. Brooklyn, NY 11249, USA

Email: --

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.